EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 7-Nov-2025 01:11 ET (7-Nov-2025 06:11 GMT/UTC)

9-Jul-2025

AI language models show promise in predicting liver cancer treatment outcomes

Hefei Institutes of Physical Science, Chinese Academy of Sciences
Peer-Reviewed Publication

A research team led by Prof. Hai Li from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has become the first to systematically explore how large language models (LLMs) can assist in predicting liver cancer treatment responses—offering a new path toward AI-powered precision medicine.

Journal: Journal of Medical Systems

9-Jul-2025

Psilocybin delays aging, extends lifespan, Emory study suggests

Emory Health Sciences
Peer-Reviewed Publication

Emory University researchers found that psilocin, a byproduct of consuming psilocybin, or the active ingredient in psychedelic mushrooms, extends the lifespan of human cells by more than 50%. Within the same study, researchers also found that mice that received an initial low dose of psilocybin of 5 mg, followed by a monthly high dose of 15 mg for 10 months, had a 30% increase in survival compared to mice that did not receive any. These mice also displayed healthier physical features, such as improved fur quality, fewer white hairs and hair regrowth.

Journal: npj Aging
Funder: Emory University Department of Medicine, Georgia CTSA NIH Award, Emory’s Woodruff Health Sciences Center for Health in Aging

9-Jul-2025

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

Compuscript Ltd
Peer-Reviewed Publication

https://doi.org/10.1016/j.apsb.2025.04.018

This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m¹A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.

Journal: Acta Pharmaceutica Sinica B

9-Jul-2025

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

Compuscript Ltd
Peer-Reviewed Publication

https://doi.org/10.1016/j.apsb.2025.04.006

This new article publication from Acta Pharmaceutica Sinica B, discusses targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.

Journal: Acta Pharmaceutica Sinica B

9-Jul-2025

The American Society for Nutrition announces Washington, DC as Host City for NUTRITION 2026

American Society for Nutrition
Meeting Announcement

The American Society for Nutrition (ASN) is pleased to announce that NUTRITION 2026, its flagship annual meeting, will be held July 25–28, 2026, in National Harbor in Maryland, just outside Washington, DC.

9-Jul-2025

FDA-approved drugs could make nano-medicine safer, study finds

University of Colorado Anschutz Medical Campus
Peer-Reviewed Publication

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, by using drugs already approved by the FDA for unrelated conditions.

Journal: Science Advances

9-Jul-2025

Five common cancers (lung, stomach, colorectal, liver, and breast) occur more often in communities with low employment rates or low incomes, per analysis of 16 years of data on Japanese adults

PLOS
Peer-Reviewed Publication

Five common cancers (lung, stomach, colorectal, liver, and breast) occur more often in communities with low employment rates or low incomes, per analysis of 16 years of data on Japanese adults

Journal: PLOS One

9-Jul-2025

Beckerle steps down after 20 years of distinguished service as Huntsman Cancer Institute CEO

Huntsman Cancer Institute
Business Announcement

After 20 years of transformative leadership, Mary Beckerle steps down as CEO and Brad Cairns is named successor to continue advancing cancer research and care across the Mountain West.

9-Jul-2025

Dr. Arjan Gower receives grant to study targeted therapy for early-stage lung cancer

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Dr. Arjan Gower, a hematologist/oncologist at the UCLA Health Jonsson Comprehensive Cancer Center, has received a research grant from the National Comprehensive Cancer Network to study a promising new targeted therapy for early-stage non-small cell lung cancer (NSCLC) with rare EGFR mutations.

Funder: National Comprehensive Cancer Network

9-Jul-2025

Vanderbilt Health at forefront of improving head and neck surgery with fluorescence imaging to ‘light up’ nerves

Vanderbilt University Medical Center
Peer-Reviewed Publication

For the first time, a fluorescent-guided nerve imaging agent shows promise for use in humans, according to a paper published in Nature Communications. The study sought to evaluate the safety of bevonescein, a synthetic peptide-dye conjugate thought to be applicable for intraoperative nerve-specific fluorescence imaging.

Journal: Nature Communications
Funder: NIH/National Institutes of Health